The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2012Role of LRRK2 in Alpha-Synuclein-Induced Neurodegeneration
Objective/Rationale:
This project seeks to develop a robust and standardized pre-clinical model relevant to late-onset Parkinson’s disease (PD) that will identify clinically viable LRRK2 kinase... -
Therapeutics Development Initiative, 2012Peripheral Administration of XPro1595 in the Pre-clinical 6-OHDA Model of Parkinson's Disease
Objective/Rationale:
Inflammation in the brain is one of the causes of Parkinson’s disease. XPro1595 is a selective inhibitor of soluble TNF that “turns off” inflammation to stop the loss of... -
Rapid Response Innovation Awards, 2012A Pair of Neurotrophic Factor Inducing Drug Candidates
Objective/Rationale:
The brain makes proteins that are required to keep nerve cell alive and healthy. They go down in Parkinson’s disease, and cannot get into the brain when ingested. ... -
LRRK2 Cohort Working Group, 2012LRRK2 Mutations and Cancer Risk
Objective/Rationale:
Two groups have reported a possible association between carrying a LRRK2 mutation and non-skin cancers. In order to determine whether this finding is present in a... -
Rapid Response Innovation Awards, 2012Role of Brain-specific PGC-1Alpha Isoforms in Parkinson's Disease
Objective/Rationale:
Impaired mitochondrial function and enhanced oxidative stress play a major role in the pathogenesis of Parkinson’s disease (PD). PGC-1alpha is a transcriptional... -
LRRK2 in the Immune System, 2012LRRK2 Regulates Host Response to Microbial Infections
Objective/Rationale:
We recently formed a research team that comprises Parkinson’s scientists, immunologists, Crohn’s disease experts, virologists and pathologists; this, to explore a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.